Connect with us


Cannabis plus Opioids Better For Pain Control: UCSF Study

Updated on

A study that was conducted by UCSF has found that combining cannabis with opioids offers greater pain relief than using opioids in isolation, even though the long-term effects of cannabis are unknown. This was published in June 2022 in Clinical Pharmacology and Therapeutics Journal.

The doctor- led study compared opiates to cannabinoids (bioactive components in marijuana) and evaluated the effectiveness of combined therapy (opiates plus cannabinoids) for pain relief.

Pain is a major reason why many American seek treatment in the U.S. According to Donald Abrams, clinical medicine professor at UCSF and the lead researcher, “chronic pain is one of the problems that were least capable of managing.”

About 50 million American adults suffer from chronic pain, which is defined as pain that lasts for more than three months. Chronic pain can be debilitating and impoverishing to one’s quality of life. It’s estimated that chronic pain results in a loss of about $80 billion each year from lost wages.

Given that opioids are the standard treatment for chronic pain, it’s no surprise that America is wallowing in an opioid crisis that is taking away about 500,000 lives each year die to opioid overdose.

The research included 21 participants as in patients suffering from chronic pain who were being treated with sustained release morphine or oxycodone. The patient’s were offered cannabis for four consecutive days without the opioids. From the results, the researchers concluded that it may be more effective to offer lower doses of opioids in combination with cannabinoids than to offer opioids in isolation, when managing chronic pain. It appears that this will also help to wean more patients off opioids and mitigate the opioid epidemic.

The researchers have called for studies that look at different cannabis strains as well as larger randomize trials that will confirm the preliminary findings.

close News!

We’d love to keep you updated with our latest cannabis news, industry interviews, and offers.

We don’t spam! Read our privacy policy for more info.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.